We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Voluntarily Files for Chapter 11 Restructuring Strategic Alternatives Process Continues with Interest from Parties Gritstone bio, Inc. (Nasdaq: GRTS) (“Gritstone” or the “Company”), a...
-- Preliminary randomized Phase 2 data suggest GRANITE (personalized neoantigen vaccine) could drive meaningful clinical benefit in front-line metastatic microsatellite-stable colorectal cancer...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.0322 | 0.0322 | 0.0322 | 0 | 0 | CS |
4 | 0 | 0 | 0.0322 | 0.0322 | 0.0322 | 0 | 0 | CS |
12 | 0 | 0 | 0.0322 | 0.0322 | 0.0322 | 0 | 0 | CS |
26 | -0.6678 | -95.4 | 0.7 | 0.7275 | 0.031 | 8376196 | 0.0912674 | CS |
52 | -2.8078 | -98.8661971831 | 2.84 | 3.135 | 0.031 | 5435305 | 0.39811302 | CS |
156 | -6.0678 | -99.4721311475 | 6.1 | 6.1899 | 0.031 | 2624787 | 1.13313398 | CS |
260 | -10.7878 | -99.7024029575 | 10.82 | 34.67 | 0.031 | 1986839 | 3.64677825 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions